Covid-19 pandemic: Can Moderna buy its way into the $200 billion club?
Moderna Inc.’s highly effective Covid vaccine, in addition to protecting millions, is officially a cash cow. The company disclosed during its earnings presentation Aug. 5 that it expects the shot to generate $20 billion in sales this year. Now it has to…
